Free Trial
NYSE:BMEZ

BlackRock Health Sciences Term Trust (BMEZ) Stock Price, News & Analysis

BlackRock Health Sciences Term Trust logo
$14.74 +0.10 (+0.68%)
(As of 12/20/2024 05:15 PM ET)

About BlackRock Health Sciences Term Trust Stock (NYSE:BMEZ)

Key Stats

Today's Range
$14.52
$14.94
50-Day Range
$14.64
$16.03
52-Week Range
$14.38
$16.59
Volume
409,371 shs
Average Volume
280,148 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
11.47%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BlackRock Health Sciences Trust II's (BMEZ) (the 'Trust') investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trust's risk-adjusted returns.

Receive BMEZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Term Trust and its competitors with MarketBeat's FREE daily newsletter.

BMEZ Stock News Headlines

BMEZ: Remains Attractive With A Deep Discount
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
BlackRock Health Sciences Opps R
See More Headlines

BMEZ Stock Analysis - Frequently Asked Questions

BlackRock Health Sciences Term Trust's stock was trading at $14.65 at the beginning of 2024. Since then, BMEZ shares have increased by 0.6% and is now trading at $14.74.
View the best growth stocks for 2024 here
.

BlackRock Health Sciences Term Trust's top institutional shareholders include Rivernorth Capital Management LLC, Rivernorth Capital Management LLC, Sessa Capital IM L.P. and Penserra Capital Management LLC. Insiders that own company stock include Saba Capital Management, LP and Christopher Accettella.
View institutional ownership trends
.

Shares of BMEZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Term Trust investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Voya Infrastructure, Industrials and Materials Fund (IDE), PIMCO Dynamic Income Fund (PDI), DoubleLine Income Solutions Fund (DSL), Pimco Dynamic Income Opportunities Fund (PDO) and OneMain (OMF).

Company Calendar

Ex-Dividend for 11/29 Dividend
11/15/2024
Dividend Payable
11/29/2024
Ex-Dividend for 12/23 Dividend
12/16/2024
Today
12/21/2024
Dividend Payable
12/23/2024

Industry, Sector and Symbol

Sector
--
Industry
-
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$-19,693,375.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NYSE:BMEZ) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners